Abstract:SummaryThe purpose of the present study was to study the characteristics of epidemic growth factor receptor (EGFR) gene distribution in patients with non-small cell lung cancer (NSCLC), and to detect the mutation rate of EGFR gene by Sanger sequencing and amplification refractory mutation system (ARMS)-PCR. Paraffin-embedded sections of NSCLC tissues from 399 NSCLC patients diagnosed in Renmin Hospital of Wuhan University were collected, 103 of them were detected for exons 18–21 mutation of EGFR by Sanger sequencing method, 296 cases were detected for exons 18–21 mutation by ARMS-PCR method. DNA extraction of both groups was performed with Qiagen QLAamp DNA FFPE Tissue KIT. Comparisons of detection rates between the two methods were conducted by row X list chi-square test. The total mutation rate of EGFR gene detected by Sanger sequencing was 21.4%, exons 18–21 and combined mutation rates were 1.0%, 9.7%, 1.0%, 7.8% and 2.0%, respectively. And the proportions were 4.7%, 45.2%, 4.7%, 36.3% and 9.4% respectively. The total mutation rate detected by ARMS-PCR was 51.4%, exons 18–21 and combined mutation rates were 2.7%, 27%, 1.7%, 18.2% and 1.7%, respectively. The proportions were 5.3%, 52.6%, 3.3%, 35.5% and 3.3% respectively. Further analysis of mutation rate showed that there was significant difference between the two methods in detecting total mutation of EGFR gene (P<0.001). There were significant differences in mutation detection rates of exons 19 and 21 (P<0.001, P<0.05), but there were no significant differences in other exons. And there was no significant difference in mutation detection rates between the two methods. The mutation rate of EGFR gene in NSCLC patients was 50%. And exon 19 deletion was the most common mutation type, followed by exon 21 mutation. Compared with Sanger sequencing method, ARMS method is more sensitive with significant advantages in detecting exon 19 deletions and exon 21 mutations, which can be widely used in clinical detection of EGFR gene mutations. The results of this study will further guide patients with advanced NSCLC to select TKI targeted drugs, and provide clinical diagnostic basis for targeted therapy of NSCLC patients.

Simultaneous amplification of exons 18 to 21 of the EGFR gene using 5' tailed primers and a two-stage protocol

Analytic And Clinical Validation Of An Ultrasensitive, Quantitative Polymerase Chain Reaction Assay For Egfr Mutation Analysis With Circulating Tumor Dna

Detection of Epidermal Growth Factor Receptor Mutations in Small Specimens of Non-Small Cell Lung Cancer by Amplification Refractory Mutation System

Construction of the method for quantitative detection of epidermal growth factor receptor variant Ⅲ by real-time polymerase chain reaction with Taq Man probe and its application

Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes]

Multiplex-invasive Reaction-Assisted Qpcr for Quantitatively Detecting the Abundance of EGFR Exon 19 Deletions in Cfdna.

Detection of Epidermal Growth Factor Receptor Gene Mutations in Non-Small Cell Lung Cancer Using Bi-Loop Probe Specific Primer Quantitative PCR

Establishment of multiplex allele-specific blocker PCR for enrichment and detection of 4 common EGFR mutations in non-small cell lung cancer

Palindromic-assisted Self-Annealing Transcription Amplification for Reliable Genotyping of Epidermal Growth Factor Receptor Exon Mutations

Different Stories for Different EGFR Exon 19 Deletion Variants

Sensitive Genotyping Of Mutations In The Egfr Gene From Nsclc Patients Using Pcr-Goldmag Lateral Flow Device

Detection of exon 19 deletion mutation in EGFR in lung cancer by mutant-enriched polymerase chain reaction assay

EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer

Highly Sensitive and Specific Real-Time PCR by Employing Serial Invasive Reaction As a Sequence Identifier for Quantifying EGFR Mutation Abundance in Cfdna

A Simple and Rapid Method for Detecting Major Mutations of Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

Establishment of a Digital PCR Platform for Detection of EGFR T790M Mutation in Plasma Circulating DNA from NSCLC Patients

A Large-Scale, Multicentered Trial Evaluating the Sensitivity and Specificity of Digital PCR Versus ARMS-PCR for Detecting Ctdna-Based EGFR P.t790m in Non-Small-cell Lung Cancer Patients.

[EGFR Mutations Detection in Non-small Cell Lung Cancer Tissues by Real-time PCR and DNA Sequencing.].

Dna Extraction from Formalin-Fixed and Paraffin-Embedded Tissues by Triton X-100 for Effective Amplification of Egfr Gene by Polymerase Chain Reaction

A Sequential Method of Epidermal Growth Factor Receptor Mutation Detection Reduces False Negatives: A New Case with Doublet Mutations of L833v and H835l in China

Detection of EGFR Mutation in Plasma Using Multiplex Allele-Specific PCR (MAS-PCR) and Surface Enhanced Raman Spectroscopy